DE60336063D1 - Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren - Google Patents

Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren

Info

Publication number
DE60336063D1
DE60336063D1 DE60336063T DE60336063T DE60336063D1 DE 60336063 D1 DE60336063 D1 DE 60336063D1 DE 60336063 T DE60336063 T DE 60336063T DE 60336063 T DE60336063 T DE 60336063T DE 60336063 D1 DE60336063 D1 DE 60336063D1
Authority
DE
Germany
Prior art keywords
nlv
host
norwalk
kit
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60336063T
Other languages
English (en)
Inventor
Xi Jiang
Pendu Jacques Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Cincinnati Childrens Hospital Medical Center
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Cincinnati Childrens Hospital Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Cincinnati Childrens Hospital Medical Center filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of DE60336063D1 publication Critical patent/DE60336063D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
DE60336063T 2002-05-31 2003-06-02 Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren Expired - Lifetime DE60336063D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38528302P 2002-05-31 2002-05-31
US38529602P 2002-05-31 2002-05-31
PCT/US2003/017247 WO2003101176A2 (en) 2002-05-31 2003-06-02 Method, composition and kit for antigenic binding of norwalk-like viruses

Publications (1)

Publication Number Publication Date
DE60336063D1 true DE60336063D1 (de) 2011-03-31

Family

ID=29715363

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60336063T Expired - Lifetime DE60336063D1 (de) 2002-05-31 2003-06-02 Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren

Country Status (9)

Country Link
US (3) US20060057562A1 (de)
EP (1) EP1532279B1 (de)
AT (1) ATE498403T1 (de)
AU (2) AU2003273206B2 (de)
CA (1) CA2487846C (de)
DE (1) DE60336063D1 (de)
DK (1) DK1532279T3 (de)
IL (1) IL165486A0 (de)
WO (1) WO2003101176A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572862B1 (en) * 1989-11-08 2003-06-03 Baylor College Of Medicine Methods and reagents to detect and characterize Norwalk and related viruses
US20060057562A1 (en) * 2002-05-31 2006-03-16 Xi Jiang Method, composition and kit for antigenic binding of norwalk-like viruses
RU2300826C2 (ru) * 2005-08-05 2007-06-10 Василий Иванович Швейкин Инжекционный излучатель
WO2010144602A2 (en) 2009-06-09 2010-12-16 Children's Hospital Medical Center Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use
US9321803B2 (en) 2013-07-12 2016-04-26 Children's Hospital Medical Center Compositions and methods for inhibiting norovirus infection
EP3600397A4 (de) 2017-03-28 2021-01-27 Children's Hospital Medical Center Impfstoffe auf basis von norovirus-s-partikeln sowie verfahren zur herstellung und verwendung davon
CN115343485B (zh) * 2022-10-18 2023-01-06 天津德祥生物技术股份有限公司 血型抗原三糖偶联物在血型抗体检测中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916213A (en) * 1983-02-22 1990-04-10 Xoma Corporation Ribosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereof
US5643579A (en) * 1984-11-01 1997-07-01 American Home Products Corporation Oral vaccines
US5338689A (en) 1987-08-24 1994-08-16 Stiftung Fur Diagnostische Forschung Method and card for detecting antigens and/or antibodies
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US5068191A (en) * 1989-08-31 1991-11-26 The Biomembrane Institute Purified histo-blood group a glycosyltransferase and antibodies thereto
AU6643290A (en) * 1989-11-08 1991-06-13 Baylor College Of Medicine Methods and reagents to detect and characterize norwalk and related viruses
CA2029219A1 (en) * 1989-11-08 1991-05-09 Mary K. Estes Methods and reagents to detect and characterize norwalk and related viruses
FR2677767B1 (fr) * 1991-06-11 1994-10-14 Biotechnologie Ste Europeenne Procede de detection de l'infection par le virus de la diarrhee bovine, sequence nucleotidique codant pour une proteine induite par l'infection par ce virus et proteines et antigenes recombinants s'y rapportant .
EP0590060B1 (de) * 1991-06-21 1997-09-17 University Of Cincinnati Oral verabreichbare therapeutische proteine und herstellungsverfahren
US5254342A (en) * 1991-09-30 1993-10-19 University Of Southern California Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
AU3972893A (en) * 1992-04-03 1993-11-08 Baylor College Of Medicine Gene therapy using the intestine
US5374532A (en) * 1992-08-31 1994-12-20 The Biomembrane Institute Method for determining susceptibility to escherichia coli urinary tract infections and method for diagnosing secretors and nonsecretors
DE4335025A1 (de) * 1993-10-14 1995-04-20 Boehringer Ingelheim Int Endosomolytisch wirksame Partikel
US5750394A (en) * 1994-05-20 1998-05-12 The Mount Sinai Medical Center Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
US6300090B1 (en) * 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
US5861241A (en) * 1995-08-16 1999-01-19 University Of Massachusetts Monoclonal antibodies for detecting Norwalk virus
WO1997006818A1 (en) * 1995-08-18 1997-02-27 Dr. Rentschler Biotechnologie Gmbh Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection
KR970016372U (ko) * 1995-10-04 1997-05-23 음식물 쓰레기 처리장치
US5891862A (en) * 1996-03-15 1999-04-06 Geltex Pharmaceuticals, Inc. Polyvalent polymers for the treatment of rotavirus infection
IL118625A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibodies
US6225290B1 (en) * 1996-09-19 2001-05-01 The Regents Of The University Of California Systemic gene therapy by intestinal cell transformation
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US20020019991A1 (en) * 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
JP2004534088A (ja) * 2001-07-06 2004-11-11 スローン−ケッタリング・インスティテュート・フォア・キャンサー・リサーチ 癌のための多価コンジュゲートワクチン
US20060057562A1 (en) * 2002-05-31 2006-03-16 Xi Jiang Method, composition and kit for antigenic binding of norwalk-like viruses
US7443123B2 (en) * 2004-10-21 2008-10-28 Shop Vac Corporation Method and apparatus for preventing overheating in an electronically commutated motor assembly

Also Published As

Publication number Publication date
AU2009238339A1 (en) 2009-12-10
WO2003101176A2 (en) 2003-12-11
CA2487846C (en) 2012-05-29
AU2003273206B2 (en) 2009-08-20
IL165486A0 (en) 2006-01-15
US8026221B2 (en) 2011-09-27
EP1532279B1 (de) 2011-02-16
DK1532279T3 (da) 2011-05-23
EP1532279A4 (de) 2005-11-09
US20060057562A1 (en) 2006-03-16
WO2003101176A3 (en) 2005-03-24
WO2003101176A8 (en) 2005-11-10
ATE498403T1 (de) 2011-03-15
US20080274984A1 (en) 2008-11-06
CA2487846A1 (en) 2003-12-11
AU2009238339B2 (en) 2011-06-30
AU2003273206A1 (en) 2003-12-19
EP1532279A2 (de) 2005-05-25
US20120071436A1 (en) 2012-03-22

Similar Documents

Publication Publication Date Title
TR201820868T4 (tr) Sindirilemeyen oligosakkritler içeren besin bileşimi.
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
NO20034549L (no) Behandling av type 2 diabetes med inhibitorer av dipeptidyl peptidase IV
WO2006031398A3 (en) Compositions containing fast-leaching plasticizers for improved performance of medical devices
MX2007002883A (es) Anticuerpos humanizados contra el virus de nilo occidental y usos terapeuticos y profilacticos del mismo.
NO20031646D0 (no) Ajuvantsammensetning omfattende et immunostimulatorisk oligonukleotid og entokol
NO20026044D0 (no) Behandling av human papillomavirus
DK1385864T3 (da) Anti-VEGF-2-antistoffer
WO2007034188A3 (en) Chemo-immunotherapy method
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
UA99094C2 (ru) Способ лечения пациента с системной красной волчанкой
WO2005058961A3 (en) Antibodies specific for human galanin, and uses thereof
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
DE60121545D1 (de) Virus des porzinen reproduktiven und respiratorischen syndroms und dessen verwendung
BRPI0512503A (pt) composição que compreende ácido lático e lactoferrina
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE60336063D1 (de) Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren
NO20070351L (no) Materialer og fremgangsmater for forbedring av skalldyrhelse, -immunitet og -vekst
WO2022011110A3 (en) Compositions and methods for the diagnosis and treatment of sars-cov-2 virus infection
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
EA200100515A2 (ru) Диазепиноиндолы для лечения хронического обструктивного заболевания легких
CO5690571A2 (es) Combinacion sinergica que comprende roflumilas y (r,r)-formoterol
ATE435028T1 (de) Impfstoff gegen neisseria infektion
SE0301883D0 (sv) New use II
SE0301885D0 (sv) New use IV